21.9.24 EBOS Healthcare has reported another strong performance for the first half of the 2024 year, driven by continued organic growth as well as several strategic investments. The EBOS group also continued to deliver strong normalised growth excluding the Chemist Warehouse Australia contract, with Underlying EBITDA growing by approximately 10%, “Demonstrating the benefits of our […]